Adult Patients with Short Bowel Syndrome Treated with Teduglutide: A Descriptive Cohort Study.

Dane Christina Daoud,Katherine J P Schwenger,Hyejung Jung,Wendy Lou,David Armstrong,Matreyi Raman, J D McHattie,Donald R Duerksen,Scott Whittaker,Barbara Bielawska,Brian Jurewitsch,Leah Gramlich,Johane P Allard

JPEN. Journal of parenteral and enteral nutrition（2023）

Cited 0|Views10

No score

Abstract

Teduglutide reduces PS volume and promotes weaning in adults with SBS-IF. Lack of narcotics and longer duration of PS were associated with PS volume reduction and weaning whereas lower PS volume at baseline and fewer days of infusion were favorable in obtaining enteral autonomy. This article is protected by copyright. All rights reserved.

Translated text

Key words

chronic intestinal failure, GLP-2 receptor agonist, parenteral nutrition, short bowel syndrome

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined